Statement of Organization, Functions, and Delegations of Authority, 5008 [2023-01566]
Download as PDF
<![CDATA[
5008
Federal Register / Vol. 88, No. 17 / Thursday, January 26, 2023 / Notices
Quality Branch 3; and established Data
Quality Branch 4.
In the Division of Talent Services IV
(DTS IV) realigned the ORA Branch 1
functions to DTS III and retitled as the
Recruitment and Staffing Branch 10;
realigned the ORA Branch 2 functions to
DTS III and retitled as the Recruitment
and Staffing Branch 11; and abolished
DTS IV.
In the Division of Talent Sourcing and
Staffing (DTSS) realigned the Corporate
Recruitment and Title 38 Branch
functions and resources to the OTS
Immediate Office Executive Resources
Staff and retitled as the Scientific
Programs and Executive Resources Staff;
realigned the Scientific Staffing and
Outreach Branch functions and
resources to the OTS Immediate Office
Scientific Talent Recruitment Staff and
retitled as the Science, Technology,
Engineering, and Mathematics Outreach
Staff; realigned the Customer Care and
Data Quality Branch functions and
resources to DTS III and retitled as the
Data Quality Branch 1; and abolished
DTSS.
Under Part D, FDA, OO, OTS has been
restructured as follows:
DCNJ. ORGANIZATION. The Office of
Talent Solutions is headed by the FDA
Chief Talent Officer and includes the
following organizational units:
lotter on DSK11XQN23PROD with NOTICES1
Business Operations Staff
Policy, Programs, and Accountability Staff
Scientific Programs and Executive Resources
Staff
Science, Technology, Engineering, and
Mathematics Outreach Staff
Division of Talent Solutions I
Recruitment and Staffing Branch 1
Recruitment and Staffing Branch 2
Recruitment and Staffing Branch 3
Recruitment and Staffing Branch 4
Special Hiring and Pay Branch
Division of Talent Solutions II
Recruitment and Staffing Branch 5
Recruitment and Staffing Branch 6
Recruitment and Staffing Branch 7
Recruitment and Staffing Branch 8
Recruitment and Staffing Branch 9
Classification Branch 1
Classification Branch 2
Division of Talent Solutions III
Recruitment and Staffing Branch 10
Recruitment and Staffing Branch 11
Delegated Examining Branch
Data Quality Branch 1
Data Quality Branch 2
Data Quality Branch 3
Data Quality Branch 4
Under Part D, FDA, OO has been
restructured as follows:
DCNK. ORGANIZATION. The Office
of FDA Commissioned Corps (OFCC) is
headed by the Director of FDA
Commissioned Corps.
VerDate Sep<11>2014
17:17 Jan 25, 2023
Jkt 259001
II. Delegations of Authority
Pending further delegation, directives,
or orders by the Commissioner of Food
and Drugs, all delegations and
redelegations of authority made to
officials and employees of affected
organizational components will
continue in them or their successors
pending further redelegations, provided
they are consistent with this
reorganization.
III. Electronic Access
This reorganization is reflected in
FDA’s Staff Manual Guide (SMG).
Persons interested in seeing the
complete SMG can find it on FDA’s
website at: https://www.fda.gov/
AboutFDA/ReportsManualsForms/
StaffManualGuides/default.htm
(Authority: 44 U.S.C. 3101.)
Xavier Becerra,
Secretary of Health and Human Services.
[FR Doc. 2023–01567 Filed 1–25–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Statement of Organization, Functions,
and Delegations of Authority
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA), Office of
Operations (OO), Office of Enterprise
Management Services (OEMS) has
modified its structure. This new
organizational structure was approved
by the Deputy Secretary of Health and
Human Services on September 26, 2022,
and effective on September 26, 2022.
FOR FURTHER INFORMATION CONTACT:
Tiffany Branch, Associate Director for
Management, Office of Enterprise
Management Services, Office of
Operations, Food and Drug
Administration, 3 White Flint North,
11601 Landsdown Street, North
Rockville, MD 20852, 240–402–3156.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Introduction
Part D, Chapter D–B, (Food and Drug
Administration), the Statement of
Organization, Functions and
Delegations of Authority for the
Department of Health and Human
Services (35 FR 3685, February 25,
1970, 60 FR 56606, November 9, 1995,
64 FR 36361, July 6, 1999, 72 FR 50112,
August 30, 2007, 74 FR 41713, August
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
18, 2009, 76 FR 45270, July 28, 2011,
and 84 FR 22854, May 20, 2019) is
amended to reflect reorganization of
OEMS.
This reorganization realigned the FDA
History Office function from the Office
of the Commissioner (OC), Office of
External Affairs (OEA) to OO, OEMS
and revised the OEA and OEMS
functional statements to this function
realignment.
The Food and Drug Administration,
Office of Operations, Office of
Enterprise Management Services has
been restructured as follows:
DCNA. ORGANIZATION. OEMS is
headed by the Director of Enterprise
Management Services and includes the
following organizational units:
Division of Compliance and Conflict
Prevention
Division of Human Capital
Division of Information Governance
FDA History Office
Division of Resources Management
Division of Vendor Management
II. Delegations of Authority
Pending further delegation, directives,
or orders by the Commissioner of Food
and Drugs, all delegations and
redelegations of authority made to
officials and employees of affected
organizational components will
continue in them or their successors
pending further redelegations, provided
they are consistent with this
reorganization.
III. Electronic Access
This reorganization is reflected in
FDA’s Staff Manual Guide (SMG).
Persons interested in seeing the
complete SMG can find it on FDA’s
website at: https://www.fda.gov/
AboutFDA/ReportsManualsForms/
StaffManualGuides/default.htm.
(Authority: 44 U.S.C. 3101).
Xavier Becerra,
Secretary of Health and Human Services.
[FR Doc. 2023–01566 Filed 1–25–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2022–N–2174]
Oncologic Drugs Advisory Committee;
Notice of Meeting; Establishment of a
Public Docket; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice; establishment of a
public docket; request for comments.
ACTION:
E:\FR\FM\26JAN1.SGM
26JAN1
]]>Agencies
[Federal Register Volume 88, Number 17 (Thursday, January 26, 2023)]
[Notices]
[Page 5008]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01566]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Statement of Organization, Functions, and Delegations of
Authority
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA), Office of Operations
(OO), Office of Enterprise Management Services (OEMS) has modified its
structure. This new organizational structure was approved by the Deputy
Secretary of Health and Human Services on September 26, 2022, and
effective on September 26, 2022.
FOR FURTHER INFORMATION CONTACT: Tiffany Branch, Associate Director for
Management, Office of Enterprise Management Services, Office of
Operations, Food and Drug Administration, 3 White Flint North, 11601
Landsdown Street, North Rockville, MD 20852, 240-402-3156.
SUPPLEMENTARY INFORMATION:
I. Introduction
Part D, Chapter D-B, (Food and Drug Administration), the Statement
of Organization, Functions and Delegations of Authority for the
Department of Health and Human Services (35 FR 3685, February 25, 1970,
60 FR 56606, November 9, 1995, 64 FR 36361, July 6, 1999, 72 FR 50112,
August 30, 2007, 74 FR 41713, August 18, 2009, 76 FR 45270, July 28,
2011, and 84 FR 22854, May 20, 2019) is amended to reflect
reorganization of OEMS.
This reorganization realigned the FDA History Office function from
the Office of the Commissioner (OC), Office of External Affairs (OEA)
to OO, OEMS and revised the OEA and OEMS functional statements to this
function realignment.
The Food and Drug Administration, Office of Operations, Office of
Enterprise Management Services has been restructured as follows:
DCNA. ORGANIZATION. OEMS is headed by the Director of Enterprise
Management Services and includes the following organizational units:
Division of Compliance and Conflict Prevention
Division of Human Capital
Division of Information Governance
FDA History Office
Division of Resources Management
Division of Vendor Management
II. Delegations of Authority
Pending further delegation, directives, or orders by the
Commissioner of Food and Drugs, all delegations and redelegations of
authority made to officials and employees of affected organizational
components will continue in them or their successors pending further
redelegations, provided they are consistent with this reorganization.
III. Electronic Access
This reorganization is reflected in FDA's Staff Manual Guide (SMG).
Persons interested in seeing the complete SMG can find it on FDA's
website at: https://www.fda.gov/AboutFDA/ReportsManualsForms/StaffManualGuides/default.htm.
(Authority: 44 U.S.C. 3101).
Xavier Becerra,
Secretary of Health and Human Services.
[FR Doc. 2023-01566 Filed 1-25-23; 8:45 am]
BILLING CODE 4164-01-P
